Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Boxer

Showing results (71-80 of 328) with videos related to

Pageof 33
Sort By:
Neurology|May 10, 2013
Dissociable executive functions in behavioral variant frontotemporal and Alzheimer dementiasKatherine L Possin, Dana Feigenbaum, Katherine P Rankin, et al.
Journal of the International Neuropsychological Society : JINS|October 10, 2013
NIH EXAMINER: conceptualization and development of an executive function batteryJoel H Kramer, Dan Mungas, Katherine L Possin, et al.
Neuroimage. Clinical|October 5, 2017
Longitudinal white matter change in frontotemporal dementia subtypes and sporadic late onset Alzheimer's diseaseFanny M Elahi, Gabe Marx, Yann Cobigo, et al.
Molecular Neurobiology|April 1, 2018
MicroRNA Expression Levels Are Altered in the Cerebrospinal Fluid of Patients with Young-Onset Alzheimer's DiseasePaul M McKeever, Raphael Schneider, Foad Taghdiri, et al.
Alzheimer Disease and Associated Disorders|October 9, 2009
An open-label study of memantine treatment in 3 subtypes of frontotemporal lobar degenerationAdam L Boxer, Anne M Lipton, Kyle Womack, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 31, 2022
The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's diseaseOskar Hansson, Rebecca M Edelmayer, Adam L Boxer, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2009
Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementiaFederica Agosta, Keith A Vossel, Bruce L Miller, et al.
Annals of Clinical and Translational Neurology|April 5, 2016
Plasma neurofilament light chain predicts progression in progressive supranuclear palsyJulio C Rojas, Anna Karydas, Jee Bang, et al.
American Journal of Alzheimer'S Disease and Other Dementias|February 4, 2010
Off-label medication use in frontotemporal dementiaBei Hu, Leslie Ross, John Neuhaus, et al.
Alzheimer Disease and Associated Disorders|February 28, 2012
Patterns of striatal degeneration in frontotemporal dementiaCathra Halabi, Anasheh Halabi, David L Dean, et al.
Pageof 33

Showing results (71-80 of 328) with videos related to

Sort By:
Pageof 33
Neurology|May 10, 2013
Dissociable executive functions in behavioral variant frontotemporal and Alzheimer dementiasKatherine L Possin, Dana Feigenbaum, Katherine P Rankin, et al.
Journal of the International Neuropsychological Society : JINS|October 10, 2013
NIH EXAMINER: conceptualization and development of an executive function batteryJoel H Kramer, Dan Mungas, Katherine L Possin, et al.
Neuroimage. Clinical|October 5, 2017
Longitudinal white matter change in frontotemporal dementia subtypes and sporadic late onset Alzheimer's diseaseFanny M Elahi, Gabe Marx, Yann Cobigo, et al.
Molecular Neurobiology|April 1, 2018
MicroRNA Expression Levels Are Altered in the Cerebrospinal Fluid of Patients with Young-Onset Alzheimer's DiseasePaul M McKeever, Raphael Schneider, Foad Taghdiri, et al.
Alzheimer Disease and Associated Disorders|October 9, 2009
An open-label study of memantine treatment in 3 subtypes of frontotemporal lobar degenerationAdam L Boxer, Anne M Lipton, Kyle Womack, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 31, 2022
The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's diseaseOskar Hansson, Rebecca M Edelmayer, Adam L Boxer, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2009
Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementiaFederica Agosta, Keith A Vossel, Bruce L Miller, et al.
Annals of Clinical and Translational Neurology|April 5, 2016
Plasma neurofilament light chain predicts progression in progressive supranuclear palsyJulio C Rojas, Anna Karydas, Jee Bang, et al.
American Journal of Alzheimer'S Disease and Other Dementias|February 4, 2010
Off-label medication use in frontotemporal dementiaBei Hu, Leslie Ross, John Neuhaus, et al.
Alzheimer Disease and Associated Disorders|February 28, 2012
Patterns of striatal degeneration in frontotemporal dementiaCathra Halabi, Anasheh Halabi, David L Dean, et al.
Pageof 33